<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03823274</url>
  </required_header>
  <id_info>
    <org_study_id>YMC037</org_study_id>
    <nct_id>NCT03823274</nct_id>
  </id_info>
  <brief_title>Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients</brief_title>
  <official_title>Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yuhan Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yuhan Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This cohort study will evaluate the relatiobship of stroke recurrence and anti-platelet
      resistance in ischemic stroke patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Weeks</target_duration>
  <primary_outcome>
    <measure>evaluate the relationship of stroke recurrence and anti-platelet resitance</measure>
    <time_frame>12weeks</time_frame>
    <description>To evaluate the relationship of stroke recurrence and anti-platelet resitance in ischemic stroke patients receiving aspirin 10mmg and clopidogrel 75mg for 12weeks</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Ischemic Stroke</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin, Clopidogrel</intervention_name>
    <description>to evaluate the relationship of stroke recurrence and anti-platelet resistance in ischemic stroke patients receiving aspirin and clopidogrel</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Stroke patient
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men and women over 60 years old at the time of written consent

          2. Those admitted to the hospital within 72 hours after acute cerebral infarction and
             treated with Aspirin 100 mg and Clopidogrel 75 mg

          3. Written informed consent voluntarily signed

        Exclusion Criteria:

          1. Those with evidence other brain lesions such as brain tumors

          2. Those who need oral anticoagulants other than vitamin K antagonists or anticoagulant
             therapy of warfarin

          3. Contraindicate to Aspirin or Clopidogrel or allergic to the drug

          4. Subjects who are at risk of active pathological bleeding such as digestive ulcer and
             intracranial hemorrhage

          5. Cancer disease that can shorten life expectancy

          6. Patient's condition that may interfere with participation in study such as mental
             illness, mental retardation, dementia, drug abuse, and alcoholism

          7. Subjects other than the above unsuitable for this clinical study identified by
             Investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jei Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungnam National Universtity Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jei Kim</last_name>
    <phone>42-280-7805</phone>
    <phone_ext>82</phone_ext>
    <email>jeikim@cnu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jei Kim</last_name>
      <phone>42-252-8654</phone>
      <phone_ext>82</phone_ext>
      <email>jeikim@cnu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 24, 2019</study_first_submitted>
  <study_first_submitted_qc>January 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2019</study_first_posted>
  <last_update_submitted>June 24, 2020</last_update_submitted>
  <last_update_submitted_qc>June 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

